Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Fang Gao, Chengsuo Huang, Yiping Zhang, Ruirui Sun, Yujie Zhang, Huijun Wang & Shu Zhang. (2016) Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa. Cancer Biology & Therapy 17:6, pages 595-598.
Read now
Read now
Emanuela Palmerini, Anna Paioli & Stefano Ferrari. (2014) Emerging therapeutic targets for synovial sarcoma. Expert Review of Anticancer Therapy 14:7, pages 791-806.
Read now
Read now
Juan Martin-Liberal, Ian Judson & Charlotte Benson. (2013) Antiangiogenic approach in soft-tissue sarcomas. Expert Review of Anticancer Therapy 13:8, pages 975-982.
Read now
Read now
Bruno Vincenzi, Marianna Silletta, Gaia Schiavon, Anna Maria Frezza, Raimondo Del Vescovo, Bruno Beomonte Zobel, Daniele Santini, Angelo Paolo Dei Tos & Giuseppe Tonini. (2013) Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience. Expert Opinion on Investigational Drugs 22:1, pages 1-7.
Read now
Read now
Articles from other publishers (36)
Jiaoqi Wu, Xiaozhu Zhou, Jie Ren, Zhen Zhang, Haoyu Ju, Xiaoqi Diao, Shuyi Jiang & Jing Zhang. (2023) Glycosyltransferase-related prognostic and diagnostic biomarkers of uterine corpus endometrial carcinoma. Computers in Biology and Medicine 163, pages 107164.
Crossref
Crossref
Aikaterini Mastoraki, Dimitrios Schizas, Despoina Maria Karavolia, Antonios Smailis, Nikolaos Machairas, Michail Vailas, Adamantios Michalinos, Dimitrios Tsapralis, Ioannis Anastasiou & George Agrogiannis. (2022) Primary Synovial Sarcoma of the Kidney: Diagnostic Approach and Therapeutic Modalities for a Rare Nosological Entity. Journal of Personalized Medicine 12:9, pages 1450.
Crossref
Crossref
Xiao Feng, Ya-Lan Huang, Zhen Zhang, Ning Wang, Qing Yao, Li-Juan Pang, Feng Li & Yan Qi. (2021) The role of SYT-SSX fusion gene in tumorigenesis of synovial sarcoma. Pathology - Research and Practice 222, pages 153416.
Crossref
Crossref
Maximilian M. L. Knott, Tilman L. B. Hölting, Shunya Ohmura, Thomas Kirchner, Florencia Cidre-Aranaz & Thomas G. P. Grünewald. (2020) Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies. Cancer and Metastasis Reviews 38:4, pages 625-642.
Crossref
Crossref
Emira Ayroldi, Maria Grazia Petrillo, Maria Cristina Marchetti, Lorenza Cannarile, Simona Ronchetti, Erika Ricci, Luigi Cari, Nicola Avenia, Sonia Moretti, Efisio Puxeddu & Carlo Riccardi. (2018) Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation. Cell Death & Disease 9:3.
Crossref
Crossref
Yunjie Zhang, Gangcan Li, Xin Liu, Yanping Song, Jia Xie, Guang Li, Jingjing Ren, Hao Wang, Jiao Mou, Jinqian Dai, Feng Liu & Liang Guo. (2018) Sorafenib inhibited cell growth through the MEK/ERK signaling pathway in acute promyelocytic leukemia cells. Oncology Letters.
Crossref
Crossref
Melek M.E. Sunay, Jeremy B. Foote, James M. Leatherman, Justin P. Edwards, Todd D. Armstrong, Christopher J. Nirschl, Jessica Hicks & Leisha A. Emens. (2017) Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo. International Immunopharmacology 46, pages 112-123.
Crossref
Crossref
Changliang Peng, Hui Zhao, Wei Chen, Yan Song, Xiaoying Wang, Ji Li, Yong Qiao, Dongjin Wu, Shengzhong Ma, Xiuwen Wang & Chunzheng Gao. (2016) Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma. Oncotarget 7:41, pages 66822-66834.
Crossref
Crossref
Myrella Vlenterie, Melissa H. S. Hillebrandt-Roeffen, Esther W. M. Schaars, Uta E. Flucke, Emmy D. G. Fleuren, Anna C. Navis, William P. J. Leenders, Yvonne M. H. Versleijen-Jonkers & Winette T. A. van der Graaf. (2016) Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients. Annals of Surgical Oncology 23:9, pages 2745-2752.
Crossref
Crossref
Olga Martinho, Marcelo Campos, Guilherme Ribeiro, Valter Penna, Emílio C. Curcelli, Marcus V. Olivieri, Sandra Morini, Cristovam Scapulatempo, Lucas F. Abrahão-Machado & Rui M. Reis. (2016) Raf Kinase Inhibitor Protein Expression and Prognostic Value in Soft Tissue Sarcomas. Pathobiology 83:1, pages 41-46.
Crossref
Crossref
Francisco Martínez-Jiménez & Marc A. Marti-Renom. (2015) Ligand-Target Prediction by Structural Network Biology Using nAnnoLyze. PLOS Computational Biology 11:3, pages e1004157.
Crossref
Crossref
S.N. Dumont, D. Yang, A.G. Dumont, D. Reynoso, J-Y. Blay & J.C. Trent. (2014) Targeted polytherapy in small cell sarcoma and its association with doxorubicin. Molecular Oncology 8:8, pages 1458-1468.
Crossref
Crossref
Yusuke Minami, Shinji Kohsaka, Masumi Tsuda, Kazuhiro Yachi, Nobuaki Hatori, Mishie Tanino, Taichi Kimura, Hiroshi Nishihara, Akio Minami, Norimasa Iwasaki & Shinya Tanaka. (2014)
SS
18‐
SSX
‐regulated miR‐17 promotes tumor growth of synovial sarcoma by inhibiting p21
WAF
1/
CIP
1
. Cancer Science 105:9, pages 1152-1159.
Crossref
Crossref
HONG ZHANG, ZHIHONG LI & KAIZHONG WANG. (2014) Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo. Oncology Reports 31:4, pages 1954-1960.
Crossref
Crossref
J. Martín-Liberal, A. López-Pousa, J. Martín Broto, R. Cubedo, O. Gallego, E. Brendel, O. M. Tirado & X. García del Muro. (2013) Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study. Investigational New Drugs 32:2, pages 287-294.
Crossref
Crossref
Yali Zhang, Zonglou Guo & Lihong Xu. (2014) Tributyltin induces a G2/M cell cycle arrest in human amniotic cells via PP2A inhibition-mediated inactivation of the ERK1/2 cascades. Environmental Toxicology and Pharmacology 37:2, pages 812-818.
Crossref
Crossref
Jürgen Radons. 2014. Inflammation and Cancer. Inflammation and Cancer
259
313
.
Wei-Ye Shi, Chang-Yan Che & Li Liu. (2013) Human Interleukin 23 Receptor Induces Cell Apoptosis in Mammalian Cells by Intrinsic Mitochondrial Pathway Associated with the Down-Regulation of RAS/Mitogen-Activated Protein Kinase and Signal Transducers and Activators of Transcription factor 3 Signaling Pathways. International Journal of Molecular Sciences 14:12, pages 24656-24669.
Crossref
Crossref
Samer Salah, Sameer Yaser, Ahmed Salem, Abdellatif Al Mousa, Areej Abu Sheikha & Iyad Sultan. (2013) Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen. Medical Oncology 30:3.
Crossref
Crossref
Teddy S Nagaria, Julia L Williams, Charles Leduc, Jeremy A Squire, Peter A Greer & Waheed Sangrar. (2013) Flavopiridol Synergizes with Sorafenib to Induce Cytotoxicity and Potentiate Antitumorigenic Activity in EGFR/HER-2 and Mutant RAS/RAF Breast Cancer Model Systems. Neoplasia 15:8, pages 939-IN27.
Crossref
Crossref
Nian‐Kang Sun, Shang‐Lang Huang, Ting‐Chang Chang & Chuck C.‐K. Chao. (2013) Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk‐1‐dependent Mcl‐1 transcription and inducing Akt/GSK3β‐dependent protein degradation. Journal of Cellular Biochemistry 114:8, pages 1819-1831.
Crossref
Crossref
Mikhail Bekarev, Elisabeth C. Elsinger, Esperanza Villanueva-Siles, Ross M. Borzykowski & David S. Geller. (2013) Synovial Sarcoma of the Foot. The Journal of Foot and Ankle Surgery 52:4, pages 513-517.
Crossref
Crossref
Oussama Karroum, Lionel Mignion, Julie Kengen, Linda Karmani, Philippe Lev?que, Pierre Danhier, Julie Magat, Anne Bol, Daniel Labar, Vincent Gr?goire, Caroline Bouzin, Olivier Feron, Bernard Gallez & B?n?dicte F. Jordan. (2013)
Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and
18
F-FLT PET imaging
. Contrast Media & Molecular Imaging 8:3, pages 274-280.
Crossref
Crossref
RUSSELL P. GOLLARD & J. FRANCIS TURNER. (2012) Multimodality therapy for metastatic sarcomas confined to the lung. Oncology Letters 4:4, pages 583-587.
Crossref
Crossref
Victor Hugo Villar, Oliver V?gler, Jordi Mart?nez-Serra, Rafael Ramos, Silvia Calabuig-Fari?as, Antonio Guti?rrez, Francisca Barcel?Javier Mart?n-Broto & Regina Alemany. (2012) Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas. PLoS ONE 7:5, pages e37735.
Crossref
Crossref
Elizabeth G. Demicco, Robert G. Maki, Dina C. Lev & Alexander J. Lazar. (2012) New Therapeutic Targets in Soft Tissue Sarcoma. Advances in Anatomic Pathology 19:3, pages 170-180.
Crossref
Crossref
Chandrajit P. Raut, Yves Boucher, Dan G. Duda, Jeffrey A. Morgan, Richard Quek, Marek Ancukiewicz, Johanna Lahdenranta, J. Paul Eder, George D. Demetri & Rakesh K. Jain. (2012) Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948). PLoS ONE 7:2, pages e26331.
Crossref
Crossref
Jorge Quesada & Robert Amato. (2012) The Molecular Biology of Soft-Tissue Sarcomas and Current Trends in Therapy. Sarcoma 2012, pages 1-16.
Crossref
Crossref
Juan Martín Liberal, Laura Lagares-Tena, Miguel Sáinz-Jaspeado, Silvia Mateo-Lozano, Xavier García del Muro & Oscar M. Tirado. (2012) Targeted Therapies in Sarcomas: Challenging the Challenge. Sarcoma 2012, pages 1-13.
Crossref
Crossref
Kevin B. Jones, Malay Haldar, Joshua D. Schiffman, Lisa Cannon-AlbrightStephen L. Lessnick, Sunil Sharma, Mario R. Capecchi & R. Lor Randall. (2011) Of Mice and Men: Opportunities to Use Genetically Engineered Mouse Models of Synovial Sarcoma for Preclinical Cancer Therapeutic Evaluation. Cancer Control 18:3, pages 196-203.
Crossref
Crossref
Tzu-Ching Kuo, Hsing-Pang Lu & Chuck C.-K. Chao. (2011) The tyrosine kinase inhibitor sorafenib sensitizes hepatocellular carcinoma cells to taxol by suppressing the HURP protein. Biochemical Pharmacology 82:2, pages 184-194.
Crossref
Crossref
Mengde Cao, Yiling Xu, Je-in Youn, Roniel Cabrera, Xiaokui Zhang, Dmitry Gabrilovich, David R Nelson & Chen Liu. (2011) Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Laboratory Investigation 91:4, pages 598-608.
Crossref
Crossref
Xinchang Lu, Xiaodong Tang, Wei Guo, Tingting Ren & Hui Zhao. (2010) Sorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway. Journal of Surgical Oncology 102:7, pages 821-826.
Crossref
Crossref
Guo-Qing Tang, Tai-Qiang Yan, Wei Guo, Ting-Ting Ren, Chang-Liang Peng, Hui Zhao, Xin-Chang Lu, Fu-Long Zhao & Xiaoguang Han. (2010) (?)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells. Journal of Cancer Research and Clinical Oncology 136:8, pages 1179-1185.
Crossref
Crossref
Pooja HingoraniEdward A Kolb. (2010) Past, present and future of therapies in pediatric sarcomas. Future Oncology 6:4, pages 605-618.
Crossref
Crossref
Austin Duffy & Shivaani Kummar. (2009) Targeting mitogen-activated protein kinase kinase (MEK) in solid tumors. Targeted Oncology 4:4, pages 267-273.
Crossref
Crossref